Brahma Dhriti K, Wahlang Julie B, Marak Maxilline D, Ch Sangma Marlina
Department of Pharmacology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Mawdiangdiang, Shillong, Meghalaya, India.
J Pharmacol Pharmacother. 2013 Apr;4(2):91-4. doi: 10.4103/0976-500X.110872.
Medications probably are the single most important health care technology in preventing illness, disability, and death in the geriatric population. Age-related changes in drug disposition and pharmacodynamic responses have significant clinical implications; increased use of a number of medications raises the risk that medicine-related problems may occur. The relationship between increased use of drugs including the prescription medication and elderly is well established. Majority of ADRs (80%) causing admission or occurring in hospital are type A reactions. Although less common occurring in elderly, type B ADRs may sometimes cause serious toxicity. Studies have correlated the integral association between old age and increased rate of adverse drug reactions arising out of confounding association between age and polypharmacy contributed by age-related changes in pharmacodynamics and pharmacokinetics at least for some medical conditions. A drug combination may sometimes cause synergistic toxicity which is greater than the sum of the risks of toxicity of either agent used alone. But, strategies to increase opportunities for identifying ADRs and related problems have not been emphasised in current international policy responses especially in India to the increase in elderly population and chronic conditions. Careful epidemiological studies that encompass large numbers of elderly drug users are required to obtain this information as increased knowledge of the frequency and cost of adverse drug reactions is important in enabling both more rational therapeutic decisions by individual clinicians and more optimal social policy.
药物可能是老年人群预防疾病、残疾和死亡方面最重要的单一医疗保健技术。药物处置和药效学反应的年龄相关变化具有重大临床意义;多种药物使用的增加提高了发生药物相关问题的风险。包括处方药在内的药物使用增加与老年人之间的关系已得到充分证实。导致入院或在医院发生的大多数药物不良反应(80%)是A型反应。虽然B型药物不良反应在老年人中较少见,但有时可能会导致严重毒性。至少对于某些医疗状况,研究已经将老年与药物不良反应发生率增加之间的整体关联与年龄和多药联用之间的混杂关联联系起来,而这种混杂关联是由药效学和药代动力学的年龄相关变化导致的。药物组合有时可能会导致协同毒性,这种毒性大于单独使用任何一种药物的毒性风险之和。但是,在当前国际应对措施中,尤其是在印度,针对老年人口增加和慢性病增加的情况,尚未强调增加识别药物不良反应及相关问题机会的策略。需要开展涵盖大量老年药物使用者的详细流行病学研究来获取此类信息,因为增加对药物不良反应频率和成本的了解对于使个体临床医生做出更合理的治疗决策以及制定更优化的社会政策都很重要。